Vertex Pharmaceuticals has grown from a $7.5 billion market cap to over $120 billion as it’s commercialized several products.

Gene editing technologies have cemented their place as a valued method in the biological toolkit used by researchers around the globe.

Latest study leverages new constructs for nuclear localization signal (NLS) sequences to improve editing efficiency in human ...

On Crowncast, Enrico Pesenti explains how cancer drug resistance forms and how advanced technologies are helping researchers ...

A longstanding mystery in Parkinson's disease research has been why some individuals carrying pathogenic variants that increase their risk of PD go on to develop the disease, while others who also ...

A longstanding mystery in Parkinson's disease research has been why some individuals carrying pathogenic variants that ...

As the demand for precision and efficiency in genetic research continues to grow, Creative Biogene's CRISPR library screening service stands out, allowing scientists to quickly identify and analyze ...

CRISPR technology uncovers new key genes and pathways linked to Parkinson’s disease, offering insights into risk and ...

A study led by Northwestern Medicine used CRISPR interference to identify Commander proteins involved in Parkinson’s disease ...

A new way to deliver disease-fighting proteins throughout the brain may improve the treatment of Alzheimer's disease and ...

A new set of genes that contribute to Parkinson’s disease risk has been identified.

Shares of early-stage biotech stocks, including Biohaven ( BHVN -8.30%), Recursion Pharmaceuticals ( RXRX -3.98%), and CRISPR Therapeutics ( CRSP -1.49%), plunged in March, with the stocks down 35.3%, ...